TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,298,127 | 3,619,949 | 2,697,416 | 8,512,824 |
| Stock subscription receivable | NaN | 500,000 | NaN | NaN |
| Stock subsciption receivable | NaN | NaN | NaN | 2,997,547 |
| Other current assets | 684,156 | 501,187 | 806,429 | 1,029,088 |
| Total current assets | 6,982,283 | 4,621,136 | 3,503,845 | 12,539,459 |
| Property plant and equipment gross | 2,508,197 | 2,459,351 | 2,431,500 | NaN |
| Less accumulated depreciation and amortization | 2,182,185 | 2,158,712 | 2,136,168 | NaN |
| Property and equipment, net | 326,012 | 300,639 | 295,332 | 144,171 |
| Operating right-of-use assets | 349,633 | 384,530 | 82,707 | 122,511 |
| Other noncurrent assets | 33,769 | 33,769 | NaN | NaN |
| Goodwill | 10,738,082 | 10,738,082 | 13,554,164 | 13,554,163 |
| In-process research and development | 11,275,000 | 11,275,000 | 8,261,000 | 8,261,000 |
| Total assets | 29,704,779 | 27,353,156 | 25,697,048 | 34,621,304 |
| Accounts payable and accrued expenses | 5,860,053 | 5,522,887 | 5,480,577 | 12,093,163 |
| Note payable to former kineta employees | NaN | NaN | 493,386 | 434,000 |
| Holdback liability, payable in shares | NaN | NaN | 2,775,795 | 2,519,644 |
| Kineta severance promissory notes | NaN | 197,354 | NaN | NaN |
| Lease liabilities, current | 206,851 | 199,041 | 84,346 | 124,969 |
| Total current liabilities | 6,066,904 | 5,919,282 | 8,834,104 | 15,171,776 |
| Lease liability, long term | 250,075 | 303,627 | NaN | NaN |
| Other long-term liabilities | NaN | NaN | 84,985 | NaN |
| Deferred tax liability | 197,919 | 197,919 | NaN | NaN |
| Total liabilities | 6,514,898 | 6,420,828 | 8,919,089 | 15,171,776 |
| Preferred stock | 278,530 | 278,530 | 278,530 | 278,530 |
| Common stock, 0.001 par value, 200,000,000 shares authorized 63,578,528 and 59,336,104 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 63,578 | 59,336 | 51,255 | 49,913 |
| Additional paid-in capital | 171,571,362 | 161,779,364 | 150,869,671 | 146,438,038 |
| Accumulated deficit | -148,723,589 | -141,184,902 | -134,421,497 | -127,316,953 |
| Total stockholders' equity | 23,189,881 | 20,932,328 | 16,777,959 | 19,449,528 |
| Total liabilities and stockholders' equity | 29,704,779 | 27,353,156 | 25,697,048 | 34,621,304 |